PCI Biotech Holding ASA (OSL:PCIB)
1.398
+0.018 (1.30%)
Apr 1, 2025, 11:23 AM CET
PCI Biotech Holding ASA Revenue
In the year 2024, PCI Biotech Holding ASA had annual revenue of 6.74M NOK with 125.25% growth. PCI Biotech Holding ASA had revenue of 3.31M in the half year ending December 31, 2024, with 39.33% growth.
Revenue
6.74M
Revenue Growth
+125.25%
P/S Ratio
7.74
Revenue / Employee
1.12M
Employees
6
Market Cap
52.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.74M | 3.75M | 125.25% |
Dec 31, 2023 | 2.99M | -1.76M | -37.05% |
Dec 31, 2022 | 4.75M | -1.52M | -24.28% |
Dec 31, 2021 | 6.27M | -1.10M | -14.86% |
Dec 31, 2020 | 7.37M | -2.02M | -21.55% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 562.60M |
Nordhealth AS | 537.23M |
Photocure ASA | 525.39M |
Vistin Pharma ASA | 429.50M |
Hofseth BioCare ASA | 265.54M |
ArcticZymes Technologies ASA | 108.11M |
Omda AS | 426.27M |
Gentian Diagnostics ASA | 152.07M |